Table 1.

Demographic and clinical data of patients with varicella zoster virus infection with central nervous system involvement.

Sex (female), n (%)	28 (47.5%)
Age (years), median (IQR)	63 (45.5–76)
Clinical presentation, n (%)
(Poly)radiculitis or cranial neuritis	32 (54.2%)
Isolated meningitis	12 (20.3%)
Myelitis, encephalomyelitis, or encephalitis	12 (20.3%)
Combination radiculitis or cranial neuritis with myelitis/encephalitis or encephalomyelitis	3 (5.1%)
Days between rash and neurological symptoms, median (IQR)	7 (2–12)
Typical VZV associated rash, n (%)	53 (89.8%)
Diagnosis based on, n (%)
Positive VZV DNA PCR	44 (74.6%)
Typical clinical features and elevated CSF cell count	3 (5.1%)
Increased CSF VZV IgG	12 (20.3%)

VZV, varicella zoster virus; IQR, interquartile range; n, number.